Cite
APA Citation
Gan, L., Lagerström‐Fermér, M., Ericsson, H., Nelander, K., Lindstedt, E., Michaëlsson, E., Kjaer, M., Heijer, M., Whatling, C., & Fuhr, R. (2019). safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo‐controlled, phase I study in healthy volunteers. British journal of clinical pharmacology, 85(4), 762–770. http://access.bl.uk/ark:/81055/vdc_100117761081.0x00002e